clopidogrel has been researched along with Inflammation in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 24 (35.29) | 29.6817 |
| 2010's | 36 (52.94) | 24.3611 |
| 2020's | 8 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Adali, MK; Buber, I; Kilic, O; Turkoz, A; Yilmaz, S | 1 |
| Han, X | 1 |
| Arthur, JM; Arulprakash, N; Corken, A; Dai, J; Davis, O; Hedayati, SS; Jain, N; Mehta, JL; Phadnis, MA; Rahmatallah, Y; Smyth, S; Ware, J | 1 |
| Heo, TH; Jeong, YJ; Lee, HR; Park, KY | 1 |
| Choi, SG; Kang, JW; Kim, DW; Kim, SK; Shin, HJ; Song, HJ; Yi, YY | 1 |
| Korish, AA | 1 |
| Dong, DX; Meng, XB; Qu, MW; Sun, GB; Sun, XB; Zhao, LY; Zhu, T | 1 |
| Deng, L; Jia, HZ; Li, MC; Zhu, W | 1 |
| de Mast, Q; El Messaoudi, S; Gerretsen, J; Gomes, M; Kiers, D; Kox, M; Pickkers, P; Riksen, NP; Rongen, GA; van der Heijden, WA; van der Ven, AJ; van Ede, L | 1 |
| Deng, HF; Li, T; Liu, K; Liu, MD; Miao, SY; Wang, XL; Xiao, XZ; Xiao, ZH | 1 |
| Choi, Y; Nguyen, TVT; Park, HS; Shin, YS; Suh, DH; Trinh, HKT | 1 |
| Cho, O; Heo, TH; Kim, HS; Park, KY | 1 |
| Aberg, JA; Badimon, JJ; Cavanagh, K; Escolar, G; Heyison, A; O'Brien, MP; Okoroafor, I; Rodriguez, JC; Rodriguez-Caprio, G; Weinberg, A; Zafar, MU | 1 |
| Guo, D; Han, XW; Jia, YX; Li, TF; Ma, J; Shui, SF; Yan, L; Yuan, HF | 1 |
| Bray, PF; DeLa Cadena, RA; Garcia, AE; Kunapuli, SP; Liverani, E; Rico, MC | 1 |
| Binongo, JN; Dhawan, SS; Ghazzal, ZB; Pohlel, FK; Quyyumi, AA; Ramadan, R; Syed, H | 1 |
| Gasior, M; Hawranek, M; Kaczmarski, J; Kuliczkowski, W; Laszowska, A; Polonski, L; Pres, D; Serebruany, VL; Szewczyk, M; Tajstra, M; Zeglen, S | 1 |
| Antonopoulos, A; Dimitropoulos, S; Kioufis, S; Kokkou, E; Mourouzis, K; Oikonomou, E; Papavassiliou, AG; Siasos, G; Stefanadis, C; Tousoulis, D; Tsalamandris, S; Vavuranakis, M; Zaromitidou, M; Zografos, T | 1 |
| Ajjan, RA; Dockrell, DH; Ecob, R; Faulkner, RE; Judge, HM; Khan, H; Outteridge, SN; Phoenix, F; Sabroe, I; Sangha, GK; Storey, RF; Thomas, MR; West, LE | 1 |
| Ambrus, JL; Chichelli, T; Ching, M; Janicke, D; Munschauer, F; Sawyer, R; Sternberg, D; Sternberg, Z; Yu, J | 1 |
| Bianchi, M; Di Nardo, V; Fioranelli, M; Roccia, MG | 1 |
| Di Giosia, P; Ferro, A; Layne, K; Passacquale, G | 1 |
| Costa, LG; Furlong, CE; Jarvik, GP; Marsillach, J | 1 |
| Ahn, JM; Chang, M; Kang, SJ; Kim, YH; Lee, CW; Lee, HS; Lee, SW; Moon, DH; Oh, M; Park, DW; Park, SJ; Park, SW | 1 |
| Filipiak, KJ; Janicki, PK; Kaplon-Cieslicka, A; Milanowski, L; Mirowska-Guzel, D; Opolski, G; Ozieranski, K; Peller, M; Pordzik, J; Postula, M; Rosiak, M; Tyminska, A | 1 |
| Monte, SV; Norgard, NB | 1 |
| Chan, S; Madsen, EH; Maurer-Spurej, E; Saw, J | 1 |
| Akbulut, M; Altas, Y; Baydas, A; Bilen, MN; Kutlu, M; Ozbay, Y; Polat, V | 1 |
| Antonino, MJ; Bliden, KP; Gurbel, PA; Mahla, E; Tantry, US | 1 |
| Aboujaoudé, S; Azar, RR; Badaoui, G; Barakett, V; Germanos, M; Hamdan, R; Kassab, R; Salamé, E; Sarkis, A | 1 |
| Bilodeau, ML; Simon, DI | 1 |
| Berger, PB; Brennan, DM; Charnigo, R; Dosh, K; Marso, S; Steinhubl, S; Topol, EJ; van Lente, F | 1 |
| Feng, L; Jiang, J; Li, M; Ren, H; Zhang, Y; Zhu, X | 1 |
| Aichele, S; Bigalke, B; Fateh-Moghadam, S; Gawaz, M; Geisler, T; Htun, P; May, AE; Mueller, K; Ninci, E; Stellos, K | 1 |
| Hagiwara, S; Hasegawa, A; Imatomi, R; Iwasaka, H; Noguchi, T; Oyama, M; Uchida, T | 1 |
| Aichele, S; Bigalke, B; Fateh-Moghadam, S; Flather, M; Gawaz, M; Geisler, T; Herkommer, M; Htun, P; May, AE; Müller, K; Stellos, K | 1 |
| Dart, AM; Du, XJ; Gao, XM; Head, GA; Kiriazis, H; Liu, Y; Lobo, A; Shan, L | 1 |
| Dimitriou, AA; Goudevenos, IA; Kalantzi, KI; Milionis, HJ; Tselepis, AD | 1 |
| Gąsior, M; Greif, M; Kaczmarski, J; Kuliczkowski, W; Poloński, L; Pres, D | 1 |
| Calver, A; Corbett, S; Curzen, N; Dent, H; Englyst, N; Gray, H; Leadbeater, P; Morgan, J; Roderick, P; Sambu, N; Simpson, I; Warner, TD | 1 |
| Bauer, M; Claus, RA; Lösche, W; Pletz, MW; Winning, J | 1 |
| Arias-Rivas, S; Blanco, M; Castillo, J; Fernández-Ferro, J; Leira, R; Rodríguez-Yáñez, M | 1 |
| Dela Cadena, RA; Garcia, AE; Kunapuli, SP; Mada, SR; Rico, MC | 1 |
| Kocka, V; Osmancik, P; Paulu, P; Tousek, P; Widimsky, P | 1 |
| Crimizade, U; El Ghannudi, S; Gachet, C; Hess, S; Jesel, L; Morel, O; Ohlmann, P; Radulescu, B; Reydel, A; Wiesel, ML | 1 |
| Amison, R; Page, C; Pitchford, S | 1 |
| Du, J; Jia, L; Liu, O; Liu, X; Qin, Y; Wang, X; Wang, Y; Zhang, H | 1 |
| Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Kim, JM; Kim, KH; Lee, KH; Lim, KS; Park, DS; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS | 1 |
| Boddy, AW; Brandt, T; Buggle, F; Dukovic, DA; Grau, AJ; Hacke, W; Lichy, C | 1 |
| Ball, SP; Barnard, MR; Fox, ML; Frelinger, AL; Furman, MI; Krueger, LA; Linden, MD; Michelson, AD | 1 |
| Baum, H; Braun, S; Dibra, A; Dirschinger, J; Hadamitzky, M; Kastrati, A; Mehilli, J; Schömig, A; Schühlen, H | 1 |
| Eriksson, MB; Larsson, A; Lipcsey, M; Olovsson, M; Sjölin, J | 1 |
| Gossmann, J; Graff, J; Harder, S; Scheuermann, EH; Wahl, O | 1 |
| Chen, YG; Ji, QS; Li, RJ; Lü, RJ; Sun, Y; Xu, F; Zhang, Y | 1 |
| Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M | 1 |
| Algayres, JP; Baranger, B; Coutant, G; Defuentes, G; Lecoules, S; Vedrine, L | 1 |
| Davì, G; Santilli, F | 1 |
| Fehér, G; Horváth, B; Késmárky, G; Koltai, K; Tóth, K | 1 |
| Bal-dit-Sollier, C; Beygui, F; Collet, JP; Drouet, L; Henry, P; Lellouche, N; Meuleman, C; Milleron, O; Montalescot, G; Sideris, G; Slama, M; Steg, PG | 1 |
| Arnesen, H; Pettersen, AA; Seljeflot, I; Solheim, S | 1 |
| Li, M; Ren, H; Zhang, Y; Zhu, X | 1 |
| Atmaca, Y; Erol, C; Gulec, S; Ozdol, C; Rahimov, U; Turhan, S | 1 |
| Bliden, KP; Gurbel, PA; Tantry, US | 1 |
| Bobilewicz, D; Filipiak, KJ; Grabowski, M; Huczek, Z; Imiela, T; Malek, LA; Opolski, G; Spiewak, M; Szpotanska, M | 1 |
| Badimon, JJ; Bhatt, DL; Herbert, JM; Lüscher, TF; Steinhubl, SR | 1 |
| Baffour, R; Chan, R; Hellinga, D; Kolodgie, F; Pakala, R; Roy, P; Scheinowitz, M; Seabron, R; Virmani, R; Waksman, R | 1 |
| Azcona, L; Farré, J; Fernández-Ortiz, A; López-Farré, AJ; Macaya, C; Romero, J; Sacristán, D; Zamorano-León, JJ | 1 |
4 review(s) available for clopidogrel and Inflammation
| Article | Year |
|---|---|
Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics.
Topics: Cardiovascular Diseases; Clopidogrel; Humans; Inflammation; Obesity; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2017 |
[Clopidogrel and stroke].
Topics: Acute Disease; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Inflammation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Ticlopidine | 2011 |
Pharmacological modulation of the inflammatory actions of platelets.
Topics: Animals; Blood Platelets; Clopidogrel; Humans; Inflammation; NF-kappa B; Platelet Activation; Platelet Adhesiveness; Ticlopidine | 2012 |
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.
Topics: Angina, Unstable; Aspirin; Atherosclerosis; Biomarkers; Blood Platelets; Clopidogrel; Humans; Inflammation; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Ticlopidine | 2007 |
24 trial(s) available for clopidogrel and Inflammation
| Article | Year |
|---|---|
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease.
Topics: Adenosine; Clopidogrel; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome | 2023 |
A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia.
Topics: Adenosine; Administration, Intravenous; Adolescent; Adult; Aspirin; Cells, Cultured; Clopidogrel; Cytokines; Drug Therapy, Combination; Endotoxemia; Endotoxins; Healthy Volunteers; Humans; Inflammation; Inflammation Mediators; Male; Netherlands; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Young Adult | 2017 |
Targeting thrombogenicity and inflammation in chronic HIV infection.
Topics: Adult; Anti-Inflammatory Agents; Antiretroviral Therapy, Highly Active; Aspirin; Biomarkers; Blood Platelets; Clopidogrel; Coronary Thrombosis; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Gene Expression; HIV Infections; Humans; Immunity, Innate; Inflammation; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II | 2019 |
Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.
Topics: Aged; Biomarkers; Blood Vessels; Capillaries; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Elasticity; Endothelium, Vascular; Female; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Platelet Aggregation Inhibitors; Prospective Studies; Stem Cells; Ticlopidine; Vascular Stiffness | 2014 |
Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment.
Topics: Aged; Aged, 80 and over; Aspirin; Brachial Artery; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Endothelium, Vascular; Female; Genotype; Humans; Inflammation; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Real-Time Polymerase Chain Reaction; Ticlopidine; Vascular Stiffness | 2015 |
Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.
Topics: Adenosine; Anti-Inflammatory Agents; Biomarkers; Blood Platelets; Chemotaxis, Leukocyte; Clopidogrel; Cytokines; Endotoxins; England; Female; Fibrin Fibrinogen Degradation Products; Humans; Inflammation; Inflammation Mediators; Male; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Young Adult | 2015 |
Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.
Topics: Adult; Aspirin; Biomarkers; C-Reactive Protein; Cell Proliferation; Clopidogrel; Cytokines; Female; Flow Cytometry; GPI-Linked Proteins; Humans; Immunologic Factors; Inflammation; Inflammation Mediators; Influenza Vaccines; Lipopolysaccharide Receptors; London; Male; Monocytes; P-Selectin; Phenotype; Platelet Aggregation Inhibitors; Receptors, IgG; Ticlopidine; Vaccination | 2016 |
Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
Topics: Adenosine; Aged; Anti-Inflammatory Agents; Carotid Arteries; Carotid Stenosis; Clopidogrel; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Radiopharmaceuticals; Republic of Korea; Severity of Illness Index; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
New single-nucleotide polymorphisms associated with differences in platelet reactivity and their influence on survival in patients with type 2 diabetes treated with acetylsalicylic acid: an observational study.
Topics: Aged; Alleles; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Female; Genotype; Humans; Inflammation; Male; Middle Aged; Platelet Activation; Polymorphism, Single Nucleotide; Receptors, Thromboxane A2, Prostaglandin H2; Survival Analysis; Ticlopidine | 2017 |
The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Inflammation; Male; Middle Aged; Pilot Projects; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Ticlopidine | 2008 |
Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction.
Topics: Aspirin; C-Reactive Protein; Clopidogrel; Coronary Circulation; Creatine Kinase, MB Form; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2009 |
Effect of high bolus dose tirofiban on the inflammatory response following percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; CD40 Antigens; Clopidogrel; Creatine Kinase, MB Form; Female; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2010 |
Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study.
Topics: Aged; Biomarkers; C-Reactive Protein; CD40 Ligand; Clopidogrel; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Inflammation; Interleukin-6; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Thromboxane B2; Ticlopidine; Time Factors; Withholding Treatment | 2011 |
High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel.
Topics: Age Factors; Aged; Biomarkers; CD40 Ligand; Clopidogrel; Diabetes Mellitus; Drug Resistance; Female; Humans; Inflammation; Interleukin-10; Leukocyte Count; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2012 |
Leukocyte count as an independent predictor of recurrent ischemic events.
Topics: Aspirin; Biomarkers; Brain Ischemia; Cause of Death; Clopidogrel; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Risk Factors; Stroke; Ticlopidine | 2004 |
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Abciximab; Acute Disease; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Platelets; CD40 Ligand; Clopidogrel; Coronary Disease; Female; Humans; Immunoglobulin Fab Fragments; Inflammation; Leukocytes; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2005 |
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Blood Platelets; C-Reactive Protein; CD11b Antigen; CD40 Antigens; Chemokine CCL2; Clopidogrel; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Leukocytes; Male; Matrix Metalloproteinase 9; Middle Aged; Monocytes; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2005 |
Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
Topics: Adult; Aged; Angina, Unstable; Aspirin; C-Reactive Protein; Clopidogrel; Drug Therapy, Combination; Electrocardiography; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Ticlopidine; Tumor Necrosis Factor-alpha | 2006 |
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) t
Topics: Acute Disease; Adenosine Diphosphate; Aged; Biomarkers; Clopidogrel; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Platelet Aggregation; Platelet Aggregation Inhibitors; Single-Blind Method; Ticlopidine; Troponin I | 2006 |
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease.
Topics: Aspirin; Biomarkers; Chemokine CCL2; Clopidogrel; Coronary Disease; Humans; Inflammation; Ticlopidine; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Clopidogrel; Creatine Kinase, MB Form; Drug Combinations; Female; Follow-Up Studies; Humans; Inflammation; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Naproxen; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome; Troponin I | 2007 |
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study.
Topics: Aged; Biomarkers; Blood Platelets; C-Reactive Protein; Clopidogrel; Creatine Kinase, MB Form; Eptifibatide; Female; Flow Cytometry; Humans; Inflammation; Male; Middle Aged; Myocardial Ischemia; Myocardium; Necrosis; P-Selectin; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine; Tumor Necrosis Factor-alpha | 2006 |
Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects.
Topics: Aged; Aspirin; Blood Platelets; C-Reactive Protein; Clopidogrel; Drug Resistance; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine | 2007 |
Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation.
Topics: Aged; alpha 1-Antitrypsin; Clopidogrel; Drug Administration Schedule; Female; Humans; Inflammation; Infusions, Intravenous; Male; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2008 |
40 other study(ies) available for clopidogrel and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Ticagrelor improves systemic immune-inflammation index in acute coronary syndrome patients.
Topics: Acute Coronary Syndrome; Clopidogrel; Humans; Inflammation; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor | 2022 |
Inhibiting P2Y12 receptor relieves LPS-induced inflammation and endothelial dysfunction.
Topics: Acute Lung Injury; Claudin-5; Clopidogrel; Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; NF-kappa B; NF-KappaB Inhibitor alpha; Occludin; Proto-Oncogene Proteins c-akt; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Tumor Necrosis Factor-alpha | 2022 |
Comparative effectiveness of different antiplatelet agents at reducing TNF-driven inflammatory responses in a mouse model.
Topics: Animals; Cilostazol; Clopidogrel; Disease Models, Animal; Inflammation; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation Inhibitors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Preventive Effects of Neuroprotective Agents in a Neonatal Rat of Photothrombotic Stroke Model.
Topics: Animals; Animals, Newborn; Aspirin; Brain Ischemia; Clopidogrel; Disease Models, Animal; Inflammation; Neuroprotective Agents; Rats; Rose Bengal; Stroke; Ubiquinone | 2020 |
Clopidogrel Prophylaxis Abates Myocardial Ischemic Injury and Inhibits the Hyperlipidemia-Inflammation Loop in Hypercholestrolemic Mice.
Topics: Animals; Aspirin; Clopidogrel; Disease Models, Animal; Humans; Hypercholesterolemia; Hyperlipidemias; Inflammation; Male; Mice; Myocardial Ischemia; Platelet Aggregation Inhibitors | 2020 |
Xuesaitong injection (lyophilized) combined with aspirin and clopidogrel protect against focal cerebral ischemic/reperfusion injury in rats by suppressing oxidative stress and inflammation and regulating the NOX2/IL-6/STAT3 pathway.
Topics: Animals; Aspirin; Clopidogrel; Drugs, Chinese Herbal; Inflammation; Interleukin-6; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Saponins; STAT3 Transcription Factor | 2021 |
Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow-up.
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Kaplan-Meier Estimate; Male; Matrix Metalloproteinase 9; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Ticagrelor; Tirofiban; Tumor Necrosis Factor-alpha | 2021 |
Clopidogrel reduces lipopolysaccharide-induced inflammation and neutrophil-platelet aggregates in an experimental endotoxemic model.
Topics: Animals; Blood Platelets; CD40 Ligand; Clopidogrel; Endotoxemia; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice, Inbred BALB C; Models, Animal; Neutrophils; P-Selectin; Platelet Aggregation Inhibitors; Pneumonia; Purinergic P2Y Receptor Antagonists; Thromboplastin; Tumor Necrosis Factor-alpha | 2019 |
Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma.
Topics: Acetates; Animals; Asthma; Clopidogrel; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Eosinophils; Female; Inflammation; Interleukins; Leukotriene Antagonists; Mice; Mice, Inbred BALB C; Ovalbumin; Phthalic Acids; Purinergic P2Y Receptor Antagonists; Quinolines; Receptors, Leukotriene; Receptors, Purinergic P2Y12; Sulfides; Th2 Cells | 2019 |
A Comparison of the Anti-Inflammatory Effects of Four Combined Statin and Antiplatelet Therapies on Tumor Necrosis Factor-Mediated Acute Inflammation in vivo.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Cilostazol; Clopidogrel; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipopolysaccharides; Male; Mice; Platelet Aggregation Inhibitors; Pravastatin; Rosuvastatin Calcium; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
Chrysin ameliorates cerebral ischemia/reperfusion (I/R) injury in rats by regulating the PI3K/Akt/mTOR pathway.
Topics: Animals; Apoptosis; Brain Edema; Cell Line; Clopidogrel; Drug Evaluation, Preclinical; Flavonoids; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-1beta; Interleukin-6; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Superoxide Dismutase-1; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2019 |
Erosive arthritis and hepatic granuloma formation induced by peptidoglycan polysaccharide in rats is aggravated by prasugrel treatment.
Topics: Animals; Arthritis, Experimental; Clopidogrel; Cytokines; Female; Granuloma; Inflammation; Joints; Liver; Peptidoglycan; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prodrugs; Rats; Rats, Inbred Lew; Thiophenes; Ticlopidine | 2013 |
Aspirin 'resistance': impact on no-reflow, platelet and inflammatory biomarkers in diabetics after ST-segment elevation myocardial infarction.
Topics: Aged; Aspirin; Biomarkers; Clopidogrel; Diabetes Complications; Drug Resistance; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2015 |
Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Brain Ischemia; CD40 Ligand; Clopidogrel; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2016 |
Effects of Arnica comp.-Heel® on reducing cardiovascular events in patients with stable coronary disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Plants, Medicinal; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Tablets; Ticlopidine; Treatment Outcome | 2016 |
Paraoxonases-1, -2 and -3: What are their functions?
Topics: Animals; Aryldialkylphosphatase; Astrocytes; Carotid Artery Diseases; Cells, Cultured; Clopidogrel; Endoplasmic Reticulum; Female; Genotype; Homocysteine; Humans; Inflammation; Lipid Metabolism; Lipoproteins, HDL; Male; Mice; Mice, Knockout; Mitochondria; Neurons; Organophosphorus Compounds; Oxidative Stress; Platelet Aggregation Inhibitors; Quorum Sensing; Ticlopidine | 2016 |
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Apyrase; Blood Platelets; Clopidogrel; Female; Flow Cytometry; Humans; Inflammation; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine | 2009 |
Clopidogrel for the hot patient.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Drug Therapy, Combination; Humans; Inflammation; Inflammation Mediators; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pregnancy-Associated Plasma Protein-A; Risk Assessment; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Up-Regulation | 2009 |
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inflammation; Inflammation Mediators; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pregnancy-Associated Plasma Protein-A; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Stroke; Ticlopidine; Time Factors; Treatment Outcome; United States; Up-Regulation | 2009 |
Effects of clopidogrel on vascular proliferation and apoptosis in an atherosclerotic rabbit model.
Topics: Animals; Apoptosis; Atherosclerosis; Atorvastatin; C-Reactive Protein; Catheterization; Clopidogrel; Endothelium, Vascular; Heptanoic Acids; Inflammation; Male; Platelet-Derived Growth Factor; Pyrroles; Rabbits; Random Allocation; Ticlopidine; Tunica Intima | 2010 |
Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Glucose; C-Reactive Protein; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytokines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoassay; Inflammation; Male; Pilot Projects; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome | 2010 |
Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model.
Topics: Animals; Blotting, Western; Clopidogrel; HMGB1 Protein; Inflammation; Interleukin-6; Lipopolysaccharides; Liver; Lung; Male; Purinergic P2Y Receptor Antagonists; Rats; Rats, Wistar; Ticlopidine; Tumor Necrosis Factor-alpha | 2011 |
Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon; Aspirin; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Female; Humans; Inflammation; Male; Pilot Projects; Platelet Activation; Stents; Ticlopidine; Treatment Outcome | 2010 |
Role of intramural platelet thrombus in the pathogenesis of wall rupture and intra-ventricular thrombosis following acute myocardial infarction.
Topics: Animals; Aspirin; Blood Platelets; Clopidogrel; Disease Models, Animal; Hemodynamics; Inflammation; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Myocardial Infarction; Platelet Aggregation Inhibitors; Telemetry; Thrombosis; Ticlopidine; Time Factors; Ventricular Septal Rupture | 2011 |
Clopidogrel differentially affects platelet-mediated thrombosis and inflammatory response in patients with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Clopidogrel; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 2011 |
Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Diabetes Complications; Electrocardiography; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2011 |
Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model.
Topics: Animals; Clopidogrel; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Ticlopidine; Tumor Necrosis Factor-alpha | 2011 |
Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis.
Topics: Animals; Arthritis, Experimental; Clopidogrel; Cytokines; Disease Models, Animal; Drug Synergism; Female; Inflammation; Leukocytosis; Neutrophils; Peptidoglycan; Platelet Aggregation; Purinergic P2Y Receptor Antagonists; Rats; Receptors, Purinergic P2Y12; Thrombocytosis; Ticlopidine | 2011 |
The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: roles of white blood cell count and body weight.
Topics: Acute Coronary Syndrome; Aged; Body Weight; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Female; Flow Cytometry; Glycated Hemoglobin; Humans; Inflammation; Leukocyte Count; Leukocytes; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Phosphorylation; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine | 2012 |
Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Platelets; Blood Pressure Determination; Clopidogrel; Cytokines; Immunoenzyme Techniques; Inflammation; Macrophages, Peritoneal; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Receptors, Purinergic P2Y12; Ticlopidine; Vasculitis; Vasoconstrictor Agents | 2012 |
The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model.
Topics: Absorbable Implants; Animals; Aspirin; Cilostazol; Clopidogrel; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Drug-Eluting Stents; Female; Inflammation; Neointima; Platelet Aggregation Inhibitors; Polymers; Swine; Tetrazoles; Ticlopidine; Treatment Outcome | 2013 |
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Inflammation; Male; Middle Aged; Postoperative Period; Premedication; Stents; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig.
Topics: Animals; Blood Platelets; Blood Pressure; Clopidogrel; Creatinine; Endotoxins; Female; Hemostasis; Humans; Inflammation; Interleukin-6; Male; Oxygen; Platelet Aggregation Inhibitors; Random Allocation; Swine; Ticlopidine; Tumor Necrosis Factor-alpha | 2005 |
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Substance Withdrawal Syndrome; Thrombosis; Ticlopidine | 2006 |
[Accelerated atheroma with prednisone and clopidogrel].
Topics: Aged; Atherosclerosis; Carotid Stenosis; Clopidogrel; Endarterectomy; Giant Cell Arteritis; Glucocorticoids; Humans; Inflammation; Male; Necrosis; Platelet Aggregation Inhibitors; Prednisone; Ticlopidine | 2006 |
Unveiling the inflammatory face of antiplatelet drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Humans; Inflammation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Up-Regulation | 2006 |
Viscosity, hemostasis and inflammation in atherosclerotic heart diseases.
Topics: Aged; Aspirin; Blood Viscosity; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Glucose; Glycated Hemoglobin; Hemostasis; Humans; Inflammation; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; von Willebrand Factor | 2006 |
Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model.
Topics: Animals; Aspirin; Atherosclerosis; Atorvastatin; Chemokine CCL2; Clopidogrel; Diet, Atherogenic; Disease Models, Animal; Femoral Artery; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Intercellular Adhesion Molecule-1; Male; P-Selectin; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Ticlopidine; Vascular Cell Adhesion Molecule-1 | 2007 |
Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries.
Topics: Angioplasty, Balloon, Coronary; Animals; C-Reactive Protein; Clopidogrel; Endothelium, Vascular; Hypercholesterolemia; Iliac Artery; Inflammation; Macrophages; Male; P-Selectin; Platelet Aggregation Inhibitors; Rabbits; Ticlopidine; Tunica Intima | 2008 |